buy

Bavarian Nordic A/S buy melinda

Bavarian Nordic A/S

Start price

€33.34

/ 50%

Target price

27.12.17

Performance (%)

End price

€30.40

Summary

This prediction ended on with a price of €30.40. With a performance of , the BUY prediction for Bavarian Nordic A/S by melinda closed slightly in the red. melinda has 50% into this prediction

Bavarian Nordic (symbol: BAVA) is a biotechnology company that specializes in developing innovative vaccines for serious diseases such as cancer and infectious diseases like Ebola and COVID-19. The company has a broad portfolio of vaccines that are under development and has collaboration agreements with various pharmaceutical companies and government agencies. Bavarian Nordic's flagship product is its cancer vaccine known as PROSTVAC, which is currently undergoing clinical trials for the treatment of prostate cancer. The company is listed on the NASDAQ Copenhagen stock exchange and has a market capitalization of approximately $925 million as of May 2021.

Feedback

Performance without dividends (%)

Name	1w	1m	1y	3y
Bavarian Nordic A/S
iShares Core DAX®
iShares Nasdaq 100
iShares Nikkei 225®
iShares S&P 500

Comments by melinda for this prediction

In the thread Bavarian Nordic A/S diskutieren

Prediction Buy

Perf. (%)

Target price 50.000

Change

Ends at

Pharma SecteurProduits

Firmenprofil

Bavarian Nordic A / S konzentriert sich auf die Entwicklung, Herstellung und Vermarktung von Immuntherapeutika gegen Krebs sowie Impfstoffe gegen Infektionskrankheiten. Das Unternehmen betreibt im Rahmen der Immuntherapie gegen Krebs, die Krebs - Pipeline umfasst, die auf therapeutischen Impfstoffen konzentriert sich ...

melinda